Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer
Clinical trial NCT03637543 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03637543
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-18
- Primary completion
- 2023-09-30
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.